1 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Budesonide dry powder inhaler: new trials by email Literature Review of Budesonide dry powder inhaler trials Research Report on Budesonide dry powder inhaler
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| STerOids in COVID-19 Study Budesonide dry powder inhaler - Coronavirus Infection | Phase 2 | Terminated | University of Oxford | 146 | 2020-07-16 | 2021-02-08 |
| Real Life Effectiveness of Easyhaler (Orion) Budesonide Easyhaler, Budesonide dry powder inhaler - Asthma | Completed | Research in Real-Life Ltd | 24003 | 2012-09-01 | 2014-01-29 | |
| Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma Budesonide dry powder inhaler - Asthma | Phase 2 / Phase 3 | Unknown | NovaMed Pharmaceuticals Inc. | 332 | 2010-12-01 | 2011-08-23 |
Asthma (2) · COVID-19 (1) · Coronavirus Infections (1)
NovaMed Pharmaceuticals Inc. (1) · Research in Real-Life Ltd (1) · University of Oxford (1)
China (1) · United Kingdom (1)
David Price (1) · Mona Bafadhel, MBBS, PhD (1)
PMID 32738928, PMID 33388170, PMID 33844996, PMID 35397798, PMID 38746861